Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study
-
Published:2018-05-17
Issue:8
Volume:37
Page:2233-2240
-
ISSN:0770-3198
-
Container-title:Clinical Rheumatology
-
language:en
-
Short-container-title:Clin Rheumatol
Author:
Sota Jurgen, , Vitale Antonio, Insalaco Antonella, Sfriso Paolo, Lopalco Giuseppe, Emmi Giacomo, Cattalini Marco, Manna Raffaele, Cimaz Rolando, Priori Roberta, Talarico Rosaria, de Marchi Ginevra, Frassi Micol, Gallizzi Romina, Soriano Alessandra, Alessio Maria, Cammelli Daniele, Maggio Maria Cristina, Gentileschi Stefano, Marcolongo Renzo, La Torre Francesco, Fabiani Claudia, Colafrancesco Serena, Ricci Francesca, Galozzi Paola, Viapiana Ombretta, Verrecchia Elena, Pardeo Manuela, Cerrito Lucia, Cavallaro Elena, Olivieri Alma Nunzia, Paolazzi Giuseppe, Vitiello Gianfranco, Maier Armin, Silvestri Elena, Stagnaro Chiara, Valesini Guido, Mosca Marta, de Vita Salvatore, Tincani Angela, Lapadula Giovanni, Frediani Bruno, De Benedetti Fabrizio, Iannone Florenzo, Punzi Leonardo, Salvarani Carlo, Galeazzi Mauro, Angotti Rossella, Messina Mario, Tosi Gian Marco, Rigante Donato, Cantarini LucaORCID
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference29 articles.
1. Dinarello CA (2014) An expanding role for interleukin-1 blockade from gout to cancer. Mol Med 20(Suppl 1):S43–S58 2. Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, Gentileschi S, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Rigante D, Cantarini L (2016) A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study. Front Pharmacol 7:380 3. Cavalli G, Dinarello CA (2015) Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology (Oxford) 54:2134–2144 4. Lopalco G, Cantarini L, Vitale A, Iannone F, Anelli MG, Andreozzi L, Lapadula G, Galeazzi M, Rigante D (2015) Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Mediat Inflamm 2015:194864 5. Fabiani C, Sota J, Tosi GM, Franceschini R, Frediani B, Galeazzi M, Rigante D, Cantarini L (2017) The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases. Clin Rheumatol 36:2307–2318
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|